New drugs for colorecta... [Cancer Chemother Biol Response Modif. 2003] - PubMed

Supplemental Content

Review [Role of angiogenesis inhibitors in the treatment of colorectal cancer]. [Magy Onkol. 2007]
Review [Role of angiogenesis inhibitors in the treatment of colorectal cancer].
Bodoky G. Magy Onkol. 2007; 51(2):139-44. Epub 2007 Jul 29.
The role of new agents in the treatment of colorectal cancer. [Oncology. 2005]
The role of new agents in the treatment of colorectal cancer.
Ruiz de Erenchun F. Oncology. 2005; 68(2-3):162; author reply 162.
Review Bevacizumab. [Nat Rev Drug Discov. 2005]
Review Bevacizumab.
Ellis LM. Nat Rev Drug Discov. 2005 May; Suppl:S8-9.
Review Monoclonal antibodies in the treatment of advanced colorectal cancer. [Eur J Surg Oncol. 2007]
Review Monoclonal antibodies in the treatment of advanced colorectal cancer.
Capdevila J, Saura C, Macarulla T, Casado E, Ramos FJ, Tabernero J. Eur J Surg Oncol. 2007 Dec; 33 Suppl 2:S24-34. Epub 2007 Nov 5.
Review [Advances in the treatment of metastatic colorectal cancer with bevacizumab]. [Tumori. 2006]
Review [Advances in the treatment of metastatic colorectal cancer with bevacizumab].
Longo F, Mansueto G. Tumori. 2006 Sep-Oct; 92(5):suppl 1-12.

New drugs for colorectal cancer.
New drugs for colorectal cancer.
Cancer Chemother Biol Response Modif. 2003 ;21:817-29.

PubMed
Chemoradiotherapy for colorectal cancer.
Chemoradiotherapy for colorectal cancer.
Gut. 2005 Aug ;54(8):1194-202.

PubMed
Survival of patients with untreated rectal cancer.
Survival of patients with untreated rectal cancer.
J Surg Oncol. 2004 Sep 15 ;87(4):157-61.

PubMed
Adjuvant postoperative radiotherapy for colon carcinoma.
Adjuvant postoperative radiotherapy for colon carcinoma.
Cancer. 2004 Sep 15 ;101(6):1338-44.

PubMed
The intent of peer-reviewed journals.
The intent of peer-reviewed journals.
Am J Surg. 1992 Jun ;163(6):633-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.